• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜性肾病:终末期肾衰竭的预测因素

Membranous nephropathy: predictors of terminal renal failure.

作者信息

Tu W H, Petitti D B, Biava C G, Tulunay O, Hopper J

出版信息

Nephron. 1984;36(2):118-24. doi: 10.1159/000183130.

DOI:10.1159/000183130
PMID:6694777
Abstract

By univariate analysis of patients with membraneous nephropathy, terminal renal failure was associated with male sex, a large amount of proteinuria, low serum albumin concentration, low creatinine clearance rate, high serum creatinine concentration, and high systolic blood pressure, but was not associated with age or prednisone treatment. In a multivariate life table analysis that controlled for all these factors simultaneously, the risk of developing terminal renal failure was significantly independently associated only with sex, serum albumin concentration, and prednisone treatment, being higher in men, lower in those treated with prednisone, and inversely related to serum albumin. Except for the minimal electron-dense deposition, the electron microscopic findings had no predictive value.

摘要

通过对膜性肾病患者进行单因素分析,终末期肾衰竭与男性、大量蛋白尿、低血清白蛋白浓度、低肌酐清除率、高血清肌酐浓度和高收缩压相关,但与年龄或泼尼松治疗无关。在同时控制所有这些因素的多变量生存表分析中,发生终末期肾衰竭的风险仅与性别、血清白蛋白浓度和泼尼松治疗显著独立相关,男性风险更高,接受泼尼松治疗者风险更低,且与血清白蛋白呈负相关。除了最小电子致密沉积外,电子显微镜检查结果无预测价值。

相似文献

1
Membranous nephropathy: predictors of terminal renal failure.膜性肾病:终末期肾衰竭的预测因素
Nephron. 1984;36(2):118-24. doi: 10.1159/000183130.
2
The clinical course of idiopathic membranous nephropathy.特发性膜性肾病的临床病程。
Mayo Clin Proc. 1973 Oct;48(10):697-712.
3
Prednisone treatment of non-nephrotic patients with idiopathic membranous nephropathy. A prospective study.
Nephron. 1982;30(3):210-9. doi: 10.1159/000182464.
4
A case of thin basement membrane syndrome associated with idiopathic membranous nephropathy.一例与特发性膜性肾病相关的薄基底膜综合征病例。
Nihon Jinzo Gakkai Shi. 1994 Jan;36(1):57-62.
5
Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.IgA 肾病的预后因素和治疗评估:来自伊朗一个单位的报告。
Ren Fail. 2011;33(6):572-7. doi: 10.3109/0886022X.2011.585001.
6
Idiopathic membranous nephropathy: the natural history of untreated patients.
Kidney Int. 1988 Mar;33(3):708-15. doi: 10.1038/ki.1988.56.
7
Natural history of lipoid nephrosis and of membranous glomerulonephritis.脂性肾病和膜性肾小球肾炎的自然病程。
Ann Intern Med. 1968 Dec;69(6):1171-96. doi: 10.7326/0003-4819-69-6-1171.
8
Membranous nephropathy. Long-term follow-up and association with neoplasia.膜性肾病。长期随访及与肿瘤的关联。
Q J Med. 1975 Apr;44(174):207-39.
9
Dense deposit disease in children: prognostic value of clinical and pathologic indicators. The Southwest Pediatric Nephrology Study Group.儿童致密物沉积病:临床和病理指标的预后价值。西南儿科肾脏病研究组
Am J Kidney Dis. 1985 Sep;6(3):161-9. doi: 10.1016/s0272-6386(85)80020-2.
10
Nephrotic syndrome in pregnancy. Clinical, histologic and fine structural studies.
Am J Obstet Gynecol. 1973 Dec 1;117(7):867-83. doi: 10.1016/0002-9378(73)90056-2.

引用本文的文献

1
Rituximab, Use and B Cell Depletion in Patients with Membranous Nephropathy- A Retrospective, Observational Study.利妥昔单抗在膜性肾病患者中的应用及B细胞清除——一项回顾性观察研究
Indian J Nephrol. 2023 Sep-Oct;33(5):356-361. doi: 10.4103/ijn.ijn_62_22. Epub 2023 Apr 19.
2
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome.利妥昔单抗治疗的性别差异反应:一项针对大量原发性膜性肾病和持续性肾病综合征患者队列的纵向观察研究。
Front Pharmacol. 2022 Sep 2;13:958136. doi: 10.3389/fphar.2022.958136. eCollection 2022.
3
Autoimmune-mediated renal disease and hypertension.
自身免疫性介导的肾脏疾病和高血压。
Clin Sci (Lond). 2021 Sep 17;135(17):2165-2196. doi: 10.1042/CS20200955.
4
Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis.利妥昔单抗治疗特发性膜性肾病:一项荟萃分析。
Int Urol Nephrol. 2021 Jan;53(1):111-119. doi: 10.1007/s11255-020-02633-5. Epub 2020 Sep 17.
5
Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension.特发性膜性肾病伴高血压患者的临床病理特征及预后
Exp Ther Med. 2020 Apr;19(4):2615-2621. doi: 10.3892/etm.2020.8506. Epub 2020 Feb 10.
6
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.影响特发性膜性肾病长期预后的因素。
BMC Nephrol. 2017 Mar 27;18(1):104. doi: 10.1186/s12882-017-0525-6.
7
The natural history of the non-nephrotic membranous nephropathy patient.非肾病性膜性肾病患者的自然病程。
Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.
8
Membranous nephropathy in the older adult: epidemiology, diagnosis and management.老年患者的膜性肾病:流行病学、诊断与管理
Drugs Aging. 2007;24(9):717-32. doi: 10.2165/00002512-200724090-00002.
9
Idiopathic membranous nephropathy in children.儿童特发性膜性肾病
Pediatr Nephrol. 2006 Nov;21(11):1707-15. doi: 10.1007/s00467-006-0246-8. Epub 2006 Sep 2.
10
Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.用硫唑嘌呤和泼尼松龙治疗进行性肾衰竭和肾病综合征。
Postgrad Med J. 1997 Oct;73(864):647-8. doi: 10.1136/pgmj.73.864.647.